The next wave of strategy - with Steen Morvan
Part of our series “The next wave of strategy”, Coloplast SVP Steen Morvan on shifting to a more human-centric narrative to drive product differentiation.
From Gloves to Hands
How a breakthrough insight transformed a medical device company with Katriina Öberg and Casey Dusenbery, EVP and R&D Director respectively within the Gloves business area at Mölnlycke Health Care.
The next wave of strategy - with Zlatko Rihter
Part of our series “The next wave of strategy”, Zlatko Rihter, CEO of Mölnlycke, speaks to how a deep investment in customer understanding created the foundation for the company's future strategy.
The next wave of strategy - with Lars Rasmussen
Part of our series “The next wave of strategy”, Coloplast CEO Lars Rasmussen speaks to why good questions are often more important than answers in strategy creation.
The next wave of strategy - with Britt Meelby Jensen, CEO of Ambu
Part of our series “The next wave of strategy”, Ambu CEO Britt Meelby Jensen speaks to placing customers at the heart of strategy, culture as a competitive advantage, and her playbook for being a successful leader.
Leading with Perspective E05: Dr. Githinji Gitahi
Episode 5 of our podcast series, Leading with Perspective, where Dr. Githinji Gitahi, Group CEO of Amref Health Africa, speaks to the strategic journey towards lasting health change in Africa.
The Collective Memory Blindspot
Without an understanding of collective memory, companies risk pushing messages that don’t speak to the underlying emotional drivers for prescription and adherence.
Healing by design: How to Build a World-Class Children's Hospital – Live podcast
A special live episode of the ReD podcast, where ReD partners and guests explore how one Copenhagen hospital is revolutionising approaches to care as part of our special series on Authority.
Are we listening to the gut? – a Live podcast
A special edition of our podcast live from Copenhagen, Denmark, where we talk to Oluf Borbye Pedersen and Theis Brydegaard on all things gut, social eating and adherence.
When food becomes medicine
We speak to Season Health about how they started their food-as-medicine platform, adherence, and the challenge of introducing new approaches to healthcare.
We need to talk about death
Lauren Carroll and Erin Merelli of Deathwives talk desanitising the conversation around death, planning for the end, and why confronting mortality makes for better living.
The deeper issue behind the healthcare strikes: a loss of meaning
Healthcare workers are losing a sense of meaning in their work. How did we get here, and what can we do to solve this as the care system finds itself increasingly squeezed?
Scaling the ‘special sauce’ of a culture in a global organisation
Millie Arora sits down with Chris Cozic, Executive Vice President & Chief People Officer at Genmab to discuss how to scale and cultivate culture.
Phenomena S2 E5: Mental Health
How can a more social and cultural understanding of mental health offer better solutions to care?
Stepping out of the corporate comfort zone in medical care
Zlatko Rihter (CEO at Mölnlyck) speaks to Martin Gronemann about trusting the ethnographic process, embracing a customer-oriented approach, and uniting the worlds of business and social sciences to build strategy.
Deep context: A strategic approach to organisational change
Ed Whiting (Wellcome Trust’s Director of Strategy) speaks to Mads Holme about the big organisational shifts required to deliver on Wellcome’s new strategy, how deeper, more reciprocal partnerships lead to more long-term solutions, and the importance of human understanding in both effecting change and creating equitable cultures.
Being customer oriented never goes out of fashion
A conversation between Britt Meelby Jensen, CEO of AMBU A/S & Mads Holme, Managing Partner at ReD Associates.
Covid-19: Now is the Time to Reinvent the Sales Model in Healthcare
The COVID-19 pandemic has the potential to rip the band-aid off dysfunctional healthcare systems.
Journal of Cancer Survivorship: The value of immunotherapy for survivors of stage IV non-small cell lung cancer
In this groundbreaking study of cancer patients treated with immunotherapy for stage IV cancer, ReD has illuminated the particular state of patients who survive longer than their initial prognosis. These patients are able to achieve a state of normalcy, despite having a terminal condition.
White Paper: Helping People Heal
ReD worked with Cognizant, taking an outside-in perspective to study the phenomenon of healing.